July 11, 2017

A NEW FEAR OF TRUMP IMPEACHMENT COULD MOVE STOCKS, BONDS AND GOLD $GLD $NVDA $AMZN $TSLA $AAPL $QQQ $SPY $IWM $TLT $SLV $GOOG $FB $NFLX

A NEW FEAR OF TRUMP IMPEACHMENT COULD MOVE STOCKS, BONDS AND GOLD $GLD $NVDA $AMZN $TSLA $AAPL $QQQ $SPY $IWM $TLT $SLV $GOOG $FB $NFLX

Successful investors make money by preparing for scenarios without letting their politics cloud their judgement. That’s a difficult task, especially in these partisan times. But I am politically agnostic, and I see my job as helping other investors.

The chart

To understand the new development today, let us look at an annotated chart.

The chart is of the Nasdaq 100 ETF QQQ.  Similar action can be seen in the charts of the S&P 500 ETF SPY, small-cap ETF IWM,  bond ETF TLT, gold ETF GLD, and silver ETF SLV.

The reason I picked QQQ is because it has heavy weighting of popular stocks including Apple AAPL,  Amazon AMZN, -0.27% Google GOOG, GOOGL,  Facebook FB, Netflix NFLX, Nvidia NVDA,  and Tesla TSLA.Please click here or the title below to read more.

Read More

INTELLIGENCE: AMICUS THERAPUTICS JUMPS 23%, SEVEN POTENTIAL BIOTECH BUYOUT TARGETS $FOLD $BMRN $EXEL $INCY $MDVN $RARE $SGEN $TSRO

INTELLIGENCE: AMICUS THERAPUTICS JUMPS 23%, SEVEN POTENTIAL BIOTECH BUYOUT TARGETS $FOLD $BMRN $EXEL $INCY $MDVN $RARE $SGEN $TSRO

This post was just published on ZYX Buy Change Alert.

FOLD plans to submit a new drug application to FDA for the oral precision medicine migalastat for Fabry disease.  The stock is jumping on the news.

We are not recommending buying FOLD here but it can be part of a basket on a pullback as discussed below.

Based on questions you are asking us, we are republishing the prior post here:

INTELLIGENCE: SEVEN POTENTIAL BIOTECH BUYOUT TARGETS IN WAKE OF ARIA BUYOUT

For us to recommend, a stock must pass at least four of the six screens. We prefer a stock to meet all six screens.

Please click here or the title below to read more.
Read More

NEW BUY ZONE ON ARENA FOR THOSE NOT IN IT AND NEW TARGETS $ARNA

NEW BUY ZONE ON ARENA FOR THOSE NOT IN IT AND NEW TARGETS $ARNA

This post was just published on ZYX Buy Change Alert. 

New buy zone for those not in ARNA is $20.33 to $22.78.  Maximum position is 20% of the full core position size.

New target zone without a buyout is $32 to $34.  In the event of a buyout, a price in the zone of $44 to $52 is possible.

Please understand that there is high risk in buying the stock right here without waiting for a pullback.

A special note for new subscribers: Please carefully study Trade Management Guidelines for speculative positions, these are the techniques that billionaires and hedge funds use to grow richer. 

Please click here or the title below to read more.
Read More

NICE GAINS ON ARENA AS IT JUMPS 25% ON POSITIVE DRUG RESULTS, GAINS NOT AS BIG AS SOME ARE MISTAKENLY THINKING $ARNA

NICE GAINS ON ARENA AS IT JUMPS 25% ON POSITIVE DRUG RESULTS, GAINS NOT AS BIG AS SOME ARE MISTAKENLY THINKING $ARNA

This post was published on ZYX Buy Change Alert.

 

ARNA is long from $16.20.  It is trading at $25 as of this writing.  The company announced positive Phase 2 results for Ralinepag for the treatment of pulmonary arterial hypertension.

The gains are not as some are mistakenly thinking.  The stock was originally bought at $1.62. Since then there has been a 10 for 1 reverse split.  So your cost basis is $16.20 not $1.62.

What To Do Now

Those in the position may consider taking profits on one-third of the position right here around $25.  Move stops on another one-third in the zone of $19.43 to $19.68. 

Please click here or the title below to read more.
Read More

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy